Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03987191 · ClinicalTrials.gov registry record · Phase 4
Insulin Pump to Multiple Daily Injection Transition Clinical Trial
A Phase 4 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
NCT03987191 is a Phase 4 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 38 participants.
The verdict
NCT03987191, a Phase 4 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
Study Summary
This randomized controlled, two arms, investigator initiated, intervention study is aimed to examine an investigational approach in contrast to the clinical standard of 1:1 dose basal insulin conversion in an attempt to lower the incidence and/or duration of hyperglycemia after transition from insulin pump to multiple daily injections in adults with type 1 diabetes.
Interventions
- DRUG Multiple daily ijnection using Insulin Degludec and Insulin Aspart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2020-10-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03987191
The ClinicalTrials.gov registry entry for NCT03987191 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multiple daily ijnection using Insulin Degludec and Insulin Aspart is the first listed.
NCT03987191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03987191 about?
NCT03987191 is a clinical study titled "Insulin Pump to Multiple Daily Injection Transition Clinical Trial". This randomized controlled, two arms, investigator initiated, intervention study is aimed to examine an investigational approach in contrast to the clinical standard of 1:1 dose basal insulin conversion in an attempt to lower the incidence and/or duration of hyperglycemia after transition from insul...
What is the current status of trial NCT03987191?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2020-01-10. Estimated completion is 2020-10-08.
What interventions are being tested in trial NCT03987191?
The interventions under investigation include: Multiple daily ijnection using Insulin Degludec and Insulin Aspart (DRUG).
Who is sponsoring clinical trial NCT03987191?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.